Focus on Nintedanib in NSCLC and Other Tumors

Overview of attention for article published in Frontiers in Medicine, December 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

reddit: 1 Redditor

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 18 Mendeley

Summary X Reddit Dimensions citations

So far, Dimensions has found 11 publications that cite this research output.

11

The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.

Efficacy and safety of VEGFR inhibitors for recurrent ovarian cancer: a systematic review

Article in Future Oncology (August 2024)

Pathogenic mechanisms and latest therapeutic approaches for radiation-induced lung injury: A narrative review

Article in Critical Reviews in Oncology/Hematology (August 2024)

Efficacy and safety of nintedanib and docetaxel in patients with previously treated lung non-squamous non-small cell lung cancer: a multicenter retrospective real-world analysis

Article in Radiology and Oncology (September 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.